Culley Brian M
President and CEO
Culley Brian M has filed 4 SEC Form 4 filings (6 transaction rows) across 1 company, with disclosures dating back to 2025. 4 of those filings fall inside the rolling window. Most recent filing: Nov 17, 2026.
On the most recent filing, Culley Brian M is listed as President and CEO at Lineage Cell Therapeutics, Inc. Inside the rolling window, Culley Brian M reported 2 open-market purchases totaling $61K in LCTX and no open-market sales. The largest disclosed transaction in the window is a purchase of 40,500 LCTX shares on Nov 16, 2026, worth $37K.
Companies traded
Other insiders at LCTX
Insider Buying
$61K
reported purchases (SEC code P)
Insider Selling
$0
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Culley Brian M made?
Culley Brian M has filed 4 SEC Form 4 filings (6 transaction rows) across 1 company since 2025.
Which companies does Culley Brian M trade?
Culley Brian M has filed SEC Form 4 disclosures for 1 company, including LCTX.
When was Culley Brian M's most recent SEC Form 4 filing?
Culley Brian M's most recent SEC Form 4 filing on Tracefour is dated Nov 17, 2026.
What is Culley Brian M's job title?
On the most recent SEC Form 4 filings tracked by Tracefour, Culley Brian M is listed as President and CEO.
What is Culley Brian M's total buy and sell value in the current window?
Inside the rolling retention window, Culley Brian M bought $61K and sold $0 based on SEC Form 4 filings.
What was Culley Brian M's largest disclosed transaction?
The largest disclosed transaction in the current window is a purchase of 40,500 LCTX shares on 2026-11-16, worth $37K, per SEC Form 4 filings.